News

Filter

Current filters:

tacrolimusAstellas Pharma

1 to 9 of 21 results

Novartis expands transplant portfolio with first branded generic tacrolimus

04-04-2012

Swiss drug major Novartis has announced the US introduction and availability of Hecoria (tacrolimus)…

Astellas PharmaGenericsHecoriaImmunologicalsMarkets & MarketingNorth AmericaNovartisPrografSandoztacrolimus

Substitution of brand name tacrolimus with generic proves safe for transplant recipients

14-09-2011

The substitution of a brand name immunosuppressive drug with a generic (manufactured by Novartis generics…

Astellas PharmaBiotechnologyGenericsImmunologicalsPrografResearchtacrolimus

Astellas sees first-half 2009/10 profits fall; revises forecast downward

06-11-2009

Japan’s second- largest drugmaker Astellas Pharma, having reported a downturn in ordinary income…

Astellas PharmaatorvastatinFinancialFlomaxLipitorPfizerPharmaceuticalPrografProtopicSandozSolifenacin SuccinatetacrolimusTamsulosin HydrochlorideVESIcare

Astellas Announces the Outcome of its Citizen Petition in the USA

11-08-2009

Japan’s Astellas Pharma says that its North American affiliate has received notice that the US.…

Asia-PacificAstellas PharmaImmunologicalsNorth AmericaNovartisNystatinOralPharmaceuticalPrografProtopicSandoztacrolimus

Astellas walks away from CV, after "white knight" Gilead stepped in with a $1.4B bid

23-03-2009

Japanese drug major Astellas Pharma, which has been pursuing USA-based CV Therapeutics since last year,…

Ambrisentan TabletsAstellas PharmaEpoprostenol sodiumFlolanGilead SciencesGiliad SciencesLetairisPrografProtopicRanexaRanolazinetacrolimus

1 to 9 of 21 results

COMPANY SPOTLIGHT

Menarini

Back to top